CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis C$0.02 +0.01 (+25.00%) As of 09:30 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartInsider TradesBuy This Stock About Quest PharmaTech Stock (CVE:QPT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Quest PharmaTech alerts:Sign Up Key Stats Today's RangeC$0.03▼C$0.0350-Day RangeC$0.02▼C$0.0452-Week RangeC$0.02▼C$0.05Volume3,500 shsAverage Volume56,804 shsMarket CapitalizationC$4.23 millionP/E Ratio0.83Dividend Yield6.15%Price TargetN/AConsensus RatingN/A Company Overview Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada. Read More Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QPT Stock News HeadlinesQuest PharmaTech Inc.July 15, 2026 | marketwatch.comQPT Share News TodayJune 20, 2026 | uk.investing.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.August 13 at 1:00 AM | Porter & Company (Ad)Quest PharmaTech Inc.: Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual BasisMay 31, 2026 | finanznachrichten.deQuest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual BasisMay 29, 2026 | financialpost.comFQuest PharmaTech Strengthens Board and Grants Stock Options at AGMAugust 27, 2025 | tipranks.comQuest PharmaTech Inc. (QPT.V) - Yahoo FinanceJuly 8, 2025 | ca.finance.yahoo.comQuest PharmaTech Inc. (QPTFF) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comSee More Headlines QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed this year? Quest PharmaTech's stock was trading at C$0.04 at the beginning of 2026. Since then, QPT stock has decreased by 28.6% and is now trading at C$0.03. How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athersys (ATHX) and Antibe Therapeutics (ATE). Industry, Sector and Symbol Stock ExchangeCVE SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolCVE:QPT CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Trailing Twelve Months)C$0.03 Trailing P/E Ratio0.83 Forward P/E RatioN/A P/E GrowthN/ANet Income-C$2.88 million Net MarginsN/A Pretax MarginN/A Return on Equity-6.28% Return on Assets-1.07% Debt Debt-to-Equity Ratio4.35 Current Ratio0.40 Quick Ratio0.52 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.14 per share Price / Book0.18Miscellaneous Outstanding Shares169,129,000Free FloatN/AMarket CapC$4.23 million OptionableNot Optionable Beta-0.07 The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (CVE:QPT) was last updated on 8/13/2026 by MarketBeat.com Staff. From Our PartnersThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredWhat's the Best Way to Lower RMD Taxes?Once you turn 73, the IRS requires you to take distributions from your IRA, 401(k), and other retirement accou...SmartAsset | SponsoredThree oil giants buried the same discovery for 50 yearsIn 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...Behind the Markets | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
